OCIAD1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
endothelial cell	42 studies	35% ± 13%	Explore
fibroblast	38 studies	30% ± 11%	Explore
natural killer cell	32 studies	27% ± 7%	Explore
B cell	30 studies	24% ± 8%	Explore
macrophage	30 studies	24% ± 8%	Explore
pericyte	27 studies	26% ± 7%	Explore
smooth muscle cell	24 studies	28% ± 8%	Explore
CD4-positive, alpha-beta T cell	24 studies	26% ± 7%	Explore
CD8-positive, alpha-beta T cell	24 studies	26% ± 6%	Explore
conventional dendritic cell	21 studies	27% ± 14%	Explore
regulatory T cell	20 studies	29% ± 6%	Explore
T cell	19 studies	25% ± 6%	Explore
endothelial cell of lymphatic vessel	19 studies	37% ± 11%	Explore
memory B cell	19 studies	25% ± 7%	Explore
epithelial cell	19 studies	36% ± 21%	Explore
classical monocyte	18 studies	23% ± 10%	Explore
ciliated cell	17 studies	43% ± 18%	Explore
astrocyte	17 studies	33% ± 15%	Explore
plasmacytoid dendritic cell	16 studies	32% ± 11%	Explore
basal cell	16 studies	35% ± 19%	Explore
naive B cell	16 studies	26% ± 6%	Explore
non-classical monocyte	16 studies	25% ± 12%	Explore
mast cell	15 studies	26% ± 7%	Explore
gamma-delta T cell	15 studies	30% ± 12%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	28% ± 7%	Explore
CD16-negative, CD56-bright natural killer cell, human	14 studies	29% ± 8%	Explore
capillary endothelial cell	14 studies	28% ± 9%	Explore
myofibroblast cell	14 studies	33% ± 10%	Explore
connective tissue cell	14 studies	32% ± 9%	Explore
monocyte	14 studies	21% ± 5%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	13 studies	29% ± 7%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	13 studies	30% ± 7%	Explore
oligodendrocyte	13 studies	37% ± 16%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	26% ± 8%	Explore
mature NK T cell	12 studies	28% ± 5%	Explore
vein endothelial cell	12 studies	32% ± 10%	Explore
plasma cell	11 studies	32% ± 11%	Explore
glutamatergic neuron	11 studies	48% ± 23%	Explore
oligodendrocyte precursor cell	11 studies	35% ± 15%	Explore
type I pneumocyte	10 studies	32% ± 11%	Explore
CD4-positive, alpha-beta memory T cell	10 studies	27% ± 7%	Explore
GABAergic neuron	10 studies	44% ± 22%	Explore
neuron	10 studies	47% ± 16%	Explore
endothelial cell of artery	10 studies	31% ± 6%	Explore
mesothelial cell	10 studies	36% ± 16%	Explore
microglial cell	10 studies	26% ± 8%	Explore
dendritic cell	10 studies	29% ± 18%	Explore
mucosal invariant T cell	10 studies	28% ± 5%	Explore
endothelial cell of vascular tree	10 studies	31% ± 7%	Explore
type II pneumocyte	9 studies	29% ± 13%	Explore
club cell	9 studies	28% ± 11%	Explore
effector memory CD8-positive, alpha-beta T cell	9 studies	27% ± 9%	Explore
progenitor cell	9 studies	25% ± 8%	Explore
abnormal cell	9 studies	33% ± 9%	Explore
secretory cell	8 studies	38% ± 15%	Explore
goblet cell	8 studies	28% ± 13%	Explore
leukocyte	7 studies	25% ± 6%	Explore
epithelial cell of proximal tubule	7 studies	29% ± 9%	Explore
amacrine cell	7 studies	39% ± 19%	Explore
retinal rod cell	7 studies	30% ± 9%	Explore
adipocyte	7 studies	23% ± 7%	Explore
T follicular helper cell	7 studies	28% ± 6%	Explore
alveolar macrophage	6 studies	26% ± 4%	Explore
plasmablast	6 studies	43% ± 24%	Explore
ionocyte	6 studies	27% ± 11%	Explore
effector CD8-positive, alpha-beta T cell	6 studies	28% ± 4%	Explore
kidney loop of Henle epithelial cell	6 studies	35% ± 8%	Explore
renal alpha-intercalated cell	6 studies	47% ± 8%	Explore
enterocyte	6 studies	23% ± 5%	Explore
interneuron	6 studies	50% ± 23%	Explore
retinal ganglion cell	6 studies	50% ± 26%	Explore
hematopoietic stem cell	6 studies	31% ± 11%	Explore
precursor B cell	6 studies	31% ± 9%	Explore
myeloid cell	6 studies	30% ± 14%	Explore
retina horizontal cell	6 studies	38% ± 15%	Explore
retinal cone cell	6 studies	41% ± 17%	Explore
hematopoietic precursor cell	5 studies	39% ± 15%	Explore
enteroendocrine cell	5 studies	36% ± 17%	Explore
retinal bipolar neuron	5 studies	37% ± 18%	Explore
pro-B cell	5 studies	29% ± 5%	Explore
brush cell	5 studies	27% ± 14%	Explore
cardiac muscle cell	5 studies	24% ± 1%	Explore
Mueller cell	5 studies	35% ± 9%	Explore
effector memory CD4-positive, alpha-beta T cell	5 studies	28% ± 9%	Explore
innate lymphoid cell	5 studies	29% ± 5%	Explore
hepatocyte	5 studies	39% ± 23%	Explore
transit amplifying cell	5 studies	27% ± 17%	Explore
duct epithelial cell	4 studies	19% ± 4%	Explore
respiratory goblet cell	4 studies	32% ± 17%	Explore
pancreatic A cell	4 studies	60% ± 11%	Explore
type B pancreatic cell	4 studies	64% ± 20%	Explore
mononuclear phagocyte	4 studies	31% ± 15%	Explore
exhausted T cell	4 studies	32% ± 5%	Explore
kidney distal convoluted tubule epithelial cell	4 studies	42% ± 8%	Explore
intestinal crypt stem cell	4 studies	26% ± 8%	Explore
glial cell	4 studies	31% ± 19%	Explore
erythroblast	4 studies	33% ± 19%	Explore
lymphocyte	4 studies	33% ± 12%	Explore
immature B cell	4 studies	27% ± 6%	Explore
adventitial cell	4 studies	25% ± 11%	Explore
OFF-bipolar cell	4 studies	31% ± 6%	Explore
ON-bipolar cell	4 studies	35% ± 6%	Explore
effector CD4-positive, alpha-beta T cell	4 studies	32% ± 4%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	34% ± 7%	Explore
erythrocyte	4 studies	30% ± 17%	Explore
T-helper 17 cell	4 studies	21% ± 3%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	27% ± 6%	Explore
precursor cell	3 studies	32% ± 6%	Explore
pancreatic D cell	3 studies	61% ± 17%	Explore
glomerular endothelial cell	3 studies	29% ± 5%	Explore
podocyte	3 studies	52% ± 8%	Explore
neural crest cell	3 studies	32% ± 5%	Explore
GABAergic interneuron	3 studies	29% ± 8%	Explore
extravillous trophoblast	3 studies	25% ± 5%	Explore
placental villous trophoblast	3 studies	37% ± 10%	Explore
retinal pigment epithelial cell	3 studies	46% ± 20%	Explore
serous secreting cell	3 studies	32% ± 4%	Explore
GABAergic amacrine cell	3 studies	36% ± 10%	Explore
glycinergic amacrine cell	3 studies	34% ± 6%	Explore
rod bipolar cell	3 studies	47% ± 3%	Explore
acinar cell	3 studies	35% ± 18%	Explore
myoepithelial cell	3 studies	32% ± 13%	Explore
pancreatic ductal cell	3 studies	56% ± 12%	Explore
granulocyte	3 studies	26% ± 7%	Explore
granulocyte monocyte progenitor cell	3 studies	29% ± 11%	Explore
megakaryocyte-erythroid progenitor cell	3 studies	50% ± 27%	Explore
group 3 innate lymphoid cell	3 studies	37% ± 11%	Explore
melanocyte	3 studies	24% ± 4%	Explore
granule cell	3 studies	32% ± 10%	Explore
T-helper 1 cell	3 studies	27% ± 5%	Explore
double negative thymocyte	3 studies	44% ± 16%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
brain	18 studies	37% ± 20%	Explore
lung	17 studies	32% ± 14%	Explore
peripheral blood	15 studies	30% ± 7%	Explore
intestine	11 studies	25% ± 13%	Explore
eye	11 studies	32% ± 12%	Explore
kidney	9 studies	29% ± 4%	Explore
liver	8 studies	28% ± 17%	Explore
bone marrow	5 studies	22% ± 7%	Explore
lymph node	5 studies	26% ± 4%	Explore
pancreas	4 studies	56% ± 19%	Explore
heart	4 studies	21% ± 3%	Explore
uterus	4 studies	41% ± 14%	Explore
breast	4 studies	25% ± 3%	Explore
adipose	4 studies	22% ± 4%	Explore
placenta	3 studies	31% ± 5%	Explore
adrenal gland	3 studies	23% ± 4%	Explore
thymus	3 studies	41% ± 17%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
brain	100%	8973.50	2642 / 2642	100%	113.63	705 / 705
breast	100%	5667.46	459 / 459	100%	107.99	1118 / 1118
esophagus	100%	4542.22	1445 / 1445	100%	62.83	183 / 183
ovary	100%	5733.94	180 / 180	100%	73.50	430 / 430
pancreas	100%	3223.39	328 / 328	100%	79.10	178 / 178
prostate	100%	5160.96	245 / 245	100%	101.82	502 / 502
kidney	100%	5652.90	89 / 89	100%	80.41	900 / 901
lung	100%	4479.53	576 / 578	100%	79.30	1155 / 1155
bladder	100%	5237.24	21 / 21	100%	72.82	502 / 504
adrenal gland	100%	7214.58	258 / 258	100%	119.31	229 / 230
liver	100%	4831.32	226 / 226	100%	71.70	404 / 406
thymus	100%	7033.08	653 / 653	100%	113.96	602 / 605
uterus	100%	5601.89	170 / 170	99%	74.08	456 / 459
stomach	100%	4352.92	359 / 359	99%	63.30	284 / 286
intestine	100%	5414.73	966 / 966	99%	69.58	521 / 527
skin	100%	5368.04	1809 / 1809	98%	76.91	463 / 472
adipose	100%	5379.97	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	60.00	29 / 29
muscle	100%	6060.76	803 / 803	0%	0	0 / 0
spleen	100%	4586.66	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	54.15	45 / 45
ureter	0%	0	0 / 0	100%	30.75	1 / 1
blood vessel	100%	5117.88	1333 / 1335	0%	0	0 / 0
heart	99%	5086.28	849 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	95%	64.53	76 / 80
peripheral blood	82%	2703.92	766 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

IV. Literature review

[source]

Gene name	OCIAD1
Protein name	OCIA domain containing 1 OCIA domain-containing protein 1 (Ovarian cancer immunoreactive antigen domain containing 1) (Ovarian carcinoma immunoreactive antigen) OCIA domain-containing protein 1
Synonyms	OCIA ASRIJ
Description	FUNCTION: Maintains stem cell potency (By similarity). Increases STAT3 phosphorylation and controls ERK phosphorylation (By similarity). May act as a scaffold, increasing STAT3 recruitment onto endosomes (By similarity). Involved in integrin-mediated cancer cell adhesion and colony formation in ovarian cancer . . FUNCTION: Maintains stem cell potency. Increases STAT3 phosphorylation and controls ERK phosphorylation. May act as a scaffold, increasing STAT3 recruitment onto endosomes. .
Accessions	ENST00000514981.5 D6RA54 ENST00000425583.6 [Q9NX40-4] D6RDI5 ENST00000509164.5 ENST00000508996.5 ENST00000508293.5 [Q9NX40-1] ENST00000506801.5 D6RBC5 ENST00000509664.5 ENST00000513391.2 [Q9NX40-1] ENST00000511662.5 D6RBN5 ENST00000507210.5 ENST00000444354.6 [Q9NX40-4] D6RF07 D6RIT9 D6RIV2 ENST00000504654.5 ENST00000511102.5 ENST00000513641.5 D6RF01 D6R9T5 ENST00000512236.5 D6RG39 ENST00000503016.5 D6RI08 D6R918 ENST00000509246.5 ENST00000264312.12 [Q9NX40-1] ENST00000396448.6 [Q9NX40-2] D6RDK1 ENST00000510824.5 Q9NX40 ENST00000509122.5 ENST00000509963.5 D6RDK6 D6RC55 ENST00000505922.6 ENST00000381473.7 [Q9NX40-1]

GO_0006897	Biological process	endocytosis
GO_0046427	Biological process	positive regulation of receptor signaling pathway via JAK-STAT
GO_0061484	Biological process	hematopoietic stem cell homeostasis
GO_2000736	Biological process	regulation of stem cell differentiation
GO_0005764	Cellular component	lysosome
GO_0005768	Cellular component	endosome
GO_0005794	Cellular component	Golgi apparatus
GO_0016020	Cellular component	membrane
GO_0005515	Molecular function	protein binding

OCIAD1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review